Christine Son, MD
Hematology & Oncology · Fayetteville, GANPI 1568996379
Payments from drug & device makers
Across 81 payments — averaging $29.29 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sanofi$237
- E.r. Squibb & Sons, L.L.C.$189
- AstraZeneca$183
- Stryker$163
- Pfizer$156
- Merck$149
- plus $1K from 30 others
What the payments were for
- Food & beverage$2,27296%
- Education$1014%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sanofi | 4 | $237 |
| E.r. Squibb & Sons, L.L.C. | 1 | $189 |
| AstraZeneca | 7 | $183 |
| Stryker | 1 | $163 |
| Pfizer | 8 | $156 |
| Merck | 7 | $149 |
| Sobi, Inc | 2 | $125 |
| GSK | 4 | $77 |
| Johnson & Johnson | 4 | $74 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $72 |
| Daiichi Sankyo Inc. | 3 | $71 |
| Seagen Inc. | 1 | $70 |
| Recordati_rare_diseases_inc. | 2 | $63 |
| Acrotech Biopharma Inc. | 3 | $63 |
| Amgen | 2 | $58 |
| Sun Pharmaceutical Industries Inc. | 1 | $56 |
| Eisai Inc. | 3 | $56 |
| Genentech USA, Inc. | 3 | $55 |
| Bayer | 2 | $55 |
| Beone Medicines USA, Inc. | 2 | $45 |
| Geron Corporation | 2 | $39 |
| Regeneron Healthcare Solutions, Inc. | 1 | $29 |
| EMD Serono, Inc. | 1 | $28 |
| ADC Therapeutics America, Inc. | 1 | $26 |
| Rigel Pharmaceuticals, Inc. | 1 | $25 |
| Gilead | 1 | $22 |
| Stemline Therapeutics Inc. | 1 | $22 |
| Ipsen Biopharmaceuticals, Inc | 1 | $21 |
| Bristol Myers Squibb | 1 | $21 |
| Lilly USA, LLC | 1 | $20 |
| Legend Biotech USA Inc. | 1 | $20 |
| Servier Pharmaceuticals LLC | 1 | $19 |
| Springworks Therapeutics, Inc. | 1 | $19 |
| Array Biopharma Inc | 2 | $18 |
| Fennec Pharmaceuticals, Inc. | 1 | $14 |
| Dendreon Pharmaceuticals LLC | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,372 in reported general payments places this provider in the 30th percentile of 370 hematology & oncology providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other hematology & oncology in Fayetteville
- Trevor FeinsteinFayetteville$2.2M
- Vipin Ramprasad LohiyaFayetteville$785K
- Mehmet BilenAtlanta$21.7M
- Steven McCuneMarietta$19.5M
- Ajay NookaAtlanta$19.3M
- Olatunji AleseAtlanta$15.5M
- Jonathon CohenAtlanta$8.7M
- Ticiana LealAtlanta$6.1M
- Amelia ZelnakCumming$4.4M
- Conor SteuerAtlanta$4.4M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.